NRC
CSII

North Run Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

North Run Capital’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-509,500
Closed -$9.36M – 30
2016
Q2 		$9.36M Hold
509,500
– – 1.54% 19
2016
Q1 		$5.28M Buy
+509,500
New +$5.16M 0.72% 23

Other funds holding CSII

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

North Run Capital's CSII Position: Q3 2016 in Review

North Run Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2016, closing a stake of 509,500 shares — an estimated $9.36M sold.

North Run Capital first reported a position in CSII in Q1 2016 and held it in 2 quarters. The position peaked at $9.36M in Q2 2016. 138 funds tracked by Wall St. Rank hold CSII as of Q3 2016.

  • North Run Capital reported no remaining Cardiovascular Systems, Inc. position as of Q3 2016 after selling out during the quarter.
  • North Run Capital sold 509,500 Cardiovascular Systems, Inc. shares in Q3 2016, an estimated $9.36M.
  • North Run Capital first reported a position in Cardiovascular Systems, Inc. in Q1 2016 and held it in 2 quarters.
  • North Run Capital's Cardiovascular Systems, Inc. position peaked at $9.36M in Q2 2016.
  • 138 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2016.

Based on North Run Capital's 13F filing for Q3 2016, filed 14 Nov 2016.